Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement
This clinical study was undertaken to evaluate the use of tissue-engineered bone, mesenchymal stem cells, platelet-rich plasma, and beta-tricalcium phosphate as grafting materials for maxillary sinus floor augmentation or onlay plasty with simultaneous implant placement in six patients with 3- to 5-mm alveolar crestal bone height.
All 20 implants were clinically stable at second-stage surgery and 12 months postloading. A mean increase in mineralized tissue height of 7.3 ± 4.6 mm was evident when comparing the pre- and postsurgical radiographs. Injectable tissue-engineered bone provided stable and predictable results in terms of implant success.
Read the full article here.
Authors: Ueda, Minoru; Yamada, Yoichi; Ozawa, Ryotaro; Okazaki, Yasuhiro
Source: https://openurl.ebsco.com/
Related articles
Bone regeneration is currently one of the most important and challenging tissue engineering approaches in regenerative medicine.
Endodontics 02 February 2026
Implantology 20 January 2026
Smoking as a risk factor for dental implants and implant-related surgery
Cigarette smoking is known to adversely affect wound healing, and thus may jeopardize the success of dental implantation and implant-related oral surgery.
Products 27 November 2025
Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants
Neocis, the pioneer behind the first and only U.S. FDA-cleared robotic system for dental implant surgery, today announced the launch and FDA approval of its next-generation robotic platform: Yomi...
Read more
Edra Professional Books 06 June 2026
Understanding Dental Insurance: A Practical Reference for Dental Professionals
Understanding Dental Insurance is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
New initiative invites dentists to experience DEXIS’ most advanced AI yet, built on scale, speed, and clinical trust.
News 05 June 2026
(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/C
News 05 June 2026
(Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected Will
As the University of Colorado School of Dental Medicine celebrates the graduating DDS Class of 2025, we are proud to recognize the students and faculty members whose exceptional de
Copyright © 2026 - All Rights Reserved
ISSN 2767-1178